109214-55-3
109214-55-3
Chemical Structure
Libenzapril
Synonym(s): Abutapril; CGS-16617
- CAS No.: 109214-55-3
- Formula:C18H25N3O5
- Molecular Weight:363.41
IUPAC Name: ((S)-1-(carboxymethyl)-2-oxo-2,3,4,5-tetrahydro-1H-benzo[b]azepin-3-yl)-L-lysine
InChIKey: AXTCRUUITQKBAV-KBPBESRZSA-N
SMILES: O=C1N(C2=CC=CC=C2CC[C@@H]1N[C@H](C(O)=O)CCCCN)CC(O)=O
Biological Activity: Libenzapril (Abutapril; CGS-16617) is an orally active, potent direct-acting angiotensin-converting-enzyme (ACE) inhibitor. Libenzapril has the potential for ischemia-induced heart failure research[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Libenzapril | Libenzapril (Abutapril; CGS-16617) is an orally active, potent direct-acting angiotensin-converting-enzyme (ACE) inhibitor. Libenzapril has the potential for ischemia-induced heart failure research. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
Keywords
